OMGene
OMGene is a biotechnology company focused on developing gene therapies for rare genetic diseases.
About
OMGene is a technology-driven biopharmaceutical company focused on developing and manufacturing complex generic APIs, including peptides, semi-synthetics, synthetic molecules, and oligonucleotides. They also engage in formulation development for injectables and oral peptide delivery. Omgene aims to provide affordable, high-quality healthcare solutions for therapeutic areas such as anti-cancer, anti-diabetic, infertility, and obesity. Teams look it up for Biotech, MedTech, HealthTech.
Frequently asked
What does OMGene do?
OMGene is a Biotech company that offers Services. Teams look it up for MedTech, HealthTech, Genomics. It is based in Boston, United States and was founded in 2017. Public records show about 14 people. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
Where is OMGene headquartered?
OMGene is headquartered in Boston, United States.
When was OMGene founded?
OMGene was founded in 2017.
What industry does OMGene operate in?
OMGene operates in Biotech, MedTech, HealthTech, Genomics, Drug Discovery.
How many employees does OMGene have?
OMGene has approximately 14 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.